Inventor · disambiguated record
Joseph Mcdonald
Also filed as: MCDONALD JOSEPH · MCDONALD JOSEPH J · MCDONALD JOSEPH JOHN
67 granted patents·19 pending applications·734 citations·filing 1995–2020
99Inventor score
Top patents by PatentIndex Score
86 records- 0196US10577380B2MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2019·Granted Mar 3, 2020·10 cites·4 claims
- 0294US10253040B1MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2017·Granted Apr 9, 2019·12 cites·15 claims
- 0394US9458175B2MK2 inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2015·Granted Oct 4, 2016·16 cites·32 claims
- 0493US9790235B2MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2016·Granted Oct 17, 2017·12 cites·18 claims
- 0592US9321786B2Heteroaryl compounds and uses thereofCELGENE AVILOMICS RES INC·Filed 2014·Granted Apr 26, 2016·15 cites·51 claims
- 0691US7115632B1Sulfonyl aryl or heteroaryl hydroxamic acid compoundsSEARLE & CO·Filed 2000·Granted Oct 3, 2006·33 cites·55 claims
- 0790US7339078B2Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE LLC·Filed 2006·Granted Mar 4, 2008·6 cites·18 claims
- 0890US7161033B2Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2005·Granted Jan 9, 2007·6 cites·20 claims
- 0990US6869951B1Method of changing conformation of a matrix metalloproteinasePHARMACIA CORP·Filed 2000·Granted Mar 22, 2005·60 cites·29 claims
- 1089US10138256B2MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2014·Granted Nov 27, 2018·11 cites·12 claims
- 1188US9663524B2Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitorsCELGENE CAR LLC·Filed 2014·Granted May 30, 2017·15 cites·27 claims
- 1288US6750228B1Aromatic sulfone hydroxamic acid metalloprotease inhibitorPHARMACIA CORP·Filed 2000·Granted Jun 15, 2004·35 cites·44 claims
- 1387US9695132B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2016·Granted Jul 4, 2017·5 cites·63 claims
- 1486US6683093B2Aromatic sulfone hydroxamic acids and their use as protease inhibitorsPHARMACIA CORP·Filed 2001·Granted Jan 27, 2004·27 cites·93 claims
- 1584US11584757B2MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2020·Granted Feb 21, 2023·1 cites·20 claims
- 1682US6861539B1Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2003·Granted Mar 1, 2005·10 cites·20 claims
- 1782US6316496B1Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2000·Granted Nov 13, 2001·14 cites·25 claims
- 1881US6689794B2Aromatic sulfone hydroxamates and their use as protease inhibitorsPHARMACIA CORP·Filed 2002·Granted Feb 10, 2004·12 cites·90 claims
- 1981US6683210B2Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2002·Granted Jan 27, 2004·9 cites·28 claims
- 2081US6380188B1Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2000·Granted Apr 30, 2002·9 cites·10 claims
- 2180US10189794B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2017·Granted Jan 29, 2019·2 cites·56 claims
- 2280US6388132B1Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2000·Granted May 14, 2002·10 cites·9 claims
- 2379US7119203B2Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitorsPHARMACIA CORP·Filed 2003·Granted Oct 10, 2006·11 cites·2 claims
- 2479US6673822B2Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2002·Granted Jan 6, 2004·3 cites·4 claims
- 2579US5753660ASubstituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 1996·Granted May 19, 1998·24 cites·22 claims
- 2678US6214861B1Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2000·Granted Apr 10, 2001·8 cites·11 claims
- 2777US10065966B2Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinasesCELGENE CAR LLC·Filed 2017·Granted Sep 4, 2018·2 cites·27 claims
- 2874US6696449B2Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitorsPHARMACIA CORP·Filed 2001·Granted Feb 24, 2004·8 cites·39 claims
- 2974US6407134B1Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2001·Granted Jun 18, 2002·2 cites·12 claims
- 3074US5985870ASulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 1996·Granted Nov 16, 1999·18 cites·10 claims
- 3173US7141594B2Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2003·Granted Nov 28, 2006·1 cites·8 claims
- 3273US6750233B2Aromatic sulfone hydroxamic acid metalloprotease inhibitorPHARMACIA CORP·Filed 2001·Granted Jun 15, 2004·6 cites·103 claims
- 3373US6716844B2Aromatic sulfonyl alpha-hydroxy hydroxamic acid compoundsPHARMACIA CORP·Filed 2001·Granted Apr 6, 2004·5 cites·19 claims
- 3473US6013649AThiol sulfone metalloprotease inhibitorsMONSANTO CO·Filed 1997·Granted Jan 11, 2000·35 cites·26 claims
- 3572US6730669B2Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2002·Granted May 4, 2004·3 cites·16 claims
- 3672US6150556ABis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 1995·Granted Nov 21, 2000·25 cites·7 claims
- 3771US10774052B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2019·Granted Sep 15, 2020·0 cites·31 claims
- 3871US6683078B2Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitorsPHARMACIA CORP·Filed 2002·Granted Jan 27, 2004·6 cites·37 claims
- 3971US6458785B1Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2001·Granted Oct 1, 2002·3 cites·27 claims
- 4071US5776971AHeterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 1995·Granted Jul 7, 1998·19 cites·14 claims
- 4171US2022332687A1Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2020·Application pending·0 cites
- 4270US6667307B2Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2002·Granted Dec 23, 2003·3 cites·10 claims
- 4370US6656954B2Sulfonyl divalent aryl or heteroaryl hydroxamic acid compoundsPHARMACIA CORP·Filed 2001·Granted Dec 2, 2003·3 cites·25 claims
- 4469US6890937B2Aromatic sulfone hydroxamic acid metalloprotease inhibitorPHARMACIA CORP·Filed 2003·Granted May 10, 2005·4 cites·39 claims
- 4568US5705500ASulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 1995·Granted Jan 6, 1998·26 cites·12 claims
- 4668US2008118969A1Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE LLC·Filed 2008·Application pending·0 cites
- 4767US7045518B2Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2003·Granted May 16, 2006·2 cites·7 claims
- 4867US5756533AAmino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 1995·Granted May 26, 1998·24 cites·15 claims
- 4966US6794511B2Sulfonyl aryl or heteroaryl hydroxamic acid compoundsSEARLE & CO·Filed 2000·Granted Sep 21, 2004·2 cites·26 claims
- 5066US6541489B1Aromatic sulfone hydroxamic acid metalloprotease inhibitorSEARLE & CO·Filed 1998·Granted Apr 1, 2003·21 cites·19 claims
Showing the top 50 of 86 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Joseph Mcdonald files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →